Off-label marketing: the competition for “biggest corporate fine” gets juicy

It is so important to admit when you're wrong.  So here goes... When I wrote that Astra-Zeneca paid the biggest corporate fine in American history ($520 million) for the off-label marketing of Seroquel, an atypical antipsychotic [I wrote that here]; I was wrong. (NOTE: off-label marketing is the promotion of a drug - whether amongst patients, doctors, or other... Continue Reading →

Seroquel user’s testimony for FDA’s psychopharmacology advisory committee

Philip at Furious Seasons who has been covering the AstraZeneca debacle gave me permission to post a "consumers" testimony that is going to be part of the hearings. I've barely mentioned what's going on with Seroquel and AstraZeneca lately and it's very important stuff. Do go have a visit to the second link I list... Continue Reading →

Powered by WordPress.com.

Up ↑

%d